Roxithromycin, Clarithromycin, and Azithromycin Attenuate the Injurious Effects of Bioactive Phospholipids on Human Respiratory Epithelium in Vitro

Overview

Journal Inflammation

Specialties Allergy & Immunology
Pathology

Date 1998 Jan 16

PMID 9429912

Citations 11

Authors

C Feldman

R Anderson

A J Theron

G Ramafi

P J COLE

R Wilson

Affiliations

Soon will be listed here.

Abstract

The effects of the bioactive phospholipids (PL), platelet-activating factor (PAF), lyso-PAF, and lysophosphatidylcholine (LPC) on the beat frequency and structural integrity of human ciliated respiratory epithelium were studied in vitro, in the presence or absence of polymorphonuclear leukocytes (PMNL), the antimicrobial agents, roxithromycin, clarithromycin, and azithromycin and the antioxidative enzymes catalase and superoxide dismutase (SOD). All three PL caused dose-dependent slowing of ciliary beat frequency (CBF) and epithelial damage (ED) at concentrations > or = 1 microgram/ml, which were unaffected by inclusion of the antimicrobial agents and antioxidative enzymes. When epithelial strips were exposed to the combination of PMNL and PL, there was significant potentiation of ciliary dysfunction and ED, which was ameliorated by pretreatment of the PMNL with the antimicrobial agents or by inclusion of catalase, but not SOD. These results demonstrate that LPC, PAF, and lyso-PAF cause epithelial damage by direct mechanisms which are oxidant-independent, as well as by indirect mechanisms involving phagocyte-derived reactive oxidants. Macrolides and azalide antimicrobial agents may have beneficial effects on airway inflammation in asthma and microbial infections by protecting ciliated epithelium against oxidative damage inflicted by PL-sensitized phagocytes.

Citing Articles

The Mechanism of Action and Clinical Efficacy of Low-Dose Long-Term Macrolide Therapy in Chronic Rhinosinusitis.

Ryu G, Lee E, Park S, Park M, Hong S, Jung Y Int J Mol Sci. 2023; 24(11).

PMID: 37298439 PMC: 10253369. DOI: 10.3390/ijms24119489.

Macrolides versus placebo for chronic asthma.

Undela K, Goldsmith L, Kew K, Ferrara G Cochrane Database Syst Rev. 2021; 11:CD002997.

PMID: 34807989 PMC: 8608382. DOI: 10.1002/14651858.CD002997.pub5.

Could Azithromycin Be Part of Acute Pneumonia Treatment?.

Leroy A, Caillon J, Caroff N, Broquet A, Corvec S, Asehnoune K Front Microbiol. 2021; 12:642541.

PMID: 33796090 PMC: 8008145. DOI: 10.3389/fmicb.2021.642541.

Azithromycin does not improve disease severity in acute experimental pancreatitis.

Weis S, Heindl M, Carvalho T, Jentho E, Lorenz J, Sommerer I PLoS One. 2019; 14(5):e0216614.

PMID: 31075097 PMC: 6510415. DOI: 10.1371/journal.pone.0216614.

Low-dose clarithromycin therapy modulates Th17 response in non-cystic fibrosis bronchiectasis patients.

Fouka E, Lamprianidou E, Arvanitidis K, Filidou E, Kolios G, Miltiades P Lung. 2014; 192(6):849-55.

PMID: 25016929 DOI: 10.1007/s00408-014-9619-0.

References

Takeyama K, Tamaoki J, Chiyotani A, Tagaya E, Konno K . Effect of macrolide antibiotics on ciliary motility in rabbit airway epithelium in-vitro. J Pharm Pharmacol. 1993; 45(8):756-8. DOI: 10.1111/j.2042-7158.1993.tb07104.x. View

Marquardt D, Walker L . Lysophosphatidylcholine induces mast cell secretion and protein kinase C activation. J Allergy Clin Immunol. 1991; 88(5):721-30. DOI: 10.1016/0091-6749(91)90178-q. View

Abdelghaffar H, Mtairag E, Labro M . Effects of dirithromycin and erythromycylamine on human neutrophil degranulation. Antimicrob Agents Chemother. 1994; 38(7):1548-54. PMC: 284591. DOI: 10.1128/AAC.38.7.1548. View

Chilton F, Averill F, Hubbard W, Fonteh A, Triggiani M, Liu M . Antigen-induced generation of lyso-phospholipids in human airways. J Exp Med. 1996; 183(5):2235-45. PMC: 2192563. DOI: 10.1084/jem.183.5.2235. View

Tanaka E, Kanthakumar K, Cundell D, Tsang K, Taylor G, KUZE F . The effect of erythromycin on Pseudomonas aeruginosa and neutrophil mediated epithelial damage. J Antimicrob Chemother. 1994; 33(4):765-75. DOI: 10.1093/jac/33.4.765. View

Labro M, El Benna J, Babin-Chevaye C . Comparison of the in-vitro effect of several macrolides on the oxidative burst of human neutrophils. J Antimicrob Chemother. 1989; 24(4):561-72. DOI: 10.1093/jac/24.4.561. View

Nieminen M, Moilanen E, Koskinen M, Karvonen J, Vapaatalo H . Platelet-activating factor impairs mucociliary transport and increases plasma leukotriene B4 in man. Eur Respir J. 1991; 4(5):551-60. View

Kita E, Sawaki M, Mikasa K, Hamada K, Takeuchi S, Maeda K . Alterations of host response by a long-term treatment of roxithromycin. J Antimicrob Chemother. 1993; 32(2):285-94. DOI: 10.1093/jac/32.2.285. View

Djukanovic R, Roche W, Wilson J, Beasley C, Twentyman O, Howarth R . Mucosal inflammation in asthma. Am Rev Respir Dis. 1990; 142(2):434-57. DOI: 10.1164/ajrccm/142.2.434. View

10.

Kallenbach J, Baynes R, Fine B, Dajee D, Bezwoda W . Persistent neutrophil activation in mild asthma. J Allergy Clin Immunol. 1992; 90(2):272-4. DOI: 10.1016/0091-6749(92)90084-f. View

11.

Konno S, Adachi M, Asano K, Kawazoe T, Okamoto K, Takahashi T . Influences of roxithromycin on cell-mediated immune responses. Life Sci. 1992; 51(10):PL107-12. DOI: 10.1016/0024-3205(92)90493-9. View

12.

Tamaoki J, Isono K, Sakai N, Kanemura T, Konno K . Erythromycin inhibits Cl secretion across canine tracheal epithelial cells. Eur Respir J. 1992; 5(2):234-8. View

13.

Laitinen L, Laitinen A, Haahtela T . Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis. 1993; 147(3):697-704. DOI: 10.1164/ajrccm/147.3.697. View

14.

Mehta D, Gupta S, Gaur S, Gangal S, Agrawal K . Increased leukocyte phospholipase A2 activity and plasma lysophosphatidylcholine levels in asthma and rhinitis and their relationship to airway sensitivity to histamine. Am Rev Respir Dis. 1990; 142(1):157-61. DOI: 10.1164/ajrccm/142.1.157. View

15.

Louis R, Bury T, Corhay J, Radermecker M . Acute bronchial and hematologic effects following inhalation of a single dose of PAF. Comparison between asthmatics and normal subjects. Chest. 1994; 106(4):1094-9. DOI: 10.1378/chest.106.4.1094. View

16.

Umeki S . Anti-inflammatory action of erythromycin. Its inhibitory effect on neutrophil NADPH oxidase activity. Chest. 1993; 104(4):1191-3. DOI: 10.1378/chest.104.4.1191. View

17.

Fahy J, Kim K, Liu J, Boushey H . Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol. 1995; 95(4):843-52. DOI: 10.1016/s0091-6749(95)70128-1. View

18.

Goswami S, Kivity S, Marom Z . Erythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro. Am Rev Respir Dis. 1990; 141(1):72-8. DOI: 10.1164/ajrccm/141.1.72. View

19.

Ganbo T, Hisamatsu K, Nakazawa T, Kamijo A, Murakami Y . Platelet activating factor (PAF) effects on ciliary activity of human paranasal sinus mucosa in vitro. Rhinology. 1991; 29(3):231-7. View

20.

Wenzel S . Abnormalities of cell and mediator levels in bronchoalveolar lavage fluid of patients with mild asthma. J Allergy Clin Immunol. 1996; 98(5 Pt 2):S17-21; discussion S33-40. View